feed,title,long_url,short_url
Benzinga,"PureCycle Gains From First-Mover Advantage And Unique Recycling Technology, Analyst Highlights Expansionary Moves",https://benzinga.com/analyst-ratings/analyst-color/24/10/41409452/purecycle-gains-from-first-mover-advantage-and-unique-recycling-technology-analyst-,https://da.gd/S9v3h
Benzinga,BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug,https://benzinga.com/analyst-ratings/analyst-color/24/10/41409413/bofa-upgrades-tyra-biosciences-as-investors-focus-on-preclinical-data-amid-high-ben,https://da.gd/190Ir3
Benzinga,"After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment",https://benzinga.com/general/biotech/24/10/41409405/after-failed-confirmatory-trial-gilead-withdraws-us-accelerated-approval-of-trodelvy-as-bladder-c,https://da.gd/v5sZ4B
